NCT00003410View on ClinicalTrials.gov

Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1998

Study Completion Date

June 30, 2004

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

motexafin gadolinium

PROCEDURE

magnetic resonance imaging

PROCEDURE

surgical procedure

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00003410 - Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas | Biotech Hunter | Biotech Hunter